ARCHIVES

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

This article is from The Cancer Letter archive.

Vol. 37 No. 39 | October 21, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: House Passes appropriations Bill; Senate Markup in Late Summer; Kirschstein Acting NIH Director

July 9, 1993

NCI-Approved Clinical Trials

April 26, 2002

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006